Elsevier

Placenta

Volume 28, Issues 11–12, November–December 2007, Pages 1219-1228
Placenta

Placental Defects in α7 Integrin Null Mice

https://doi.org/10.1016/j.placenta.2007.08.002Get rights and content

Abstract

The α7β1 integrin is a heterodimeric transmembrane receptor that links laminin in the extracellular matrix to the cell cytoskeleton. Loss of the α7 integrin chain results in partial embryonic lethality. We have previously shown that α7 integrin null embryos exhibit vascular smooth muscle cell defects that result in cerebral vascular hemorrhaging. Since the placenta is highly vascularized, we hypothesized that placental vascular defects in α7 integrin null embryos may contribute to the partial embryonic lethality. Placentae from embryonic day (ED) 9.5 and 13.5 α7 integrin knockout embryos showed structural defects including infiltration of the spongiotrophoblast layer into the placental labyrinth, a reduction in the placental labyrinth and loss of distinct placental layers. Embryos and placentae that lacked the α7 integrin weighed less compared to wild-type controls. Blood vessels within the placental labyrinth of α7 integrin null embryos exhibited fewer differentiated vascular smooth muscle cells compared to wild-type. Loss of the α7 integrin resulted in altered extracellular matrix deposition and reduced expression of α5 integrin. Together our results confirm a role for the α7β1 integrin in placental vascular development and demonstrate for the first time that loss of the α7 integrin results in placental defects.

Introduction

The placenta is a multifunctional organ essential for maintaining pregnancy, providing nutrients and growth factors to the fetus, removing waste and protecting the fetus from potentially harmful substances [1]. Placental dysfunction can result in insufficient fetal nutrition, which can lead to intrauterine growth restriction (IUGR) [2], [3], [4], [5], [6]. At least 8% of human pregnancies end in infant death due to complications that arise from IUGR [1], [7], [8]. Epidemiological studies indicate IUGR can have lifelong consequences by increasing the risk for heart disease, type-2 diabetes, hypertension, and stroke [9], [10], [11], [12]. Abnormalities in placental structure and function have been associated with the majority of reported cases of fetal IUGR [1].

Integrins are a diverse family of cell surface receptors that mediate the interactions between cells and the extracellular matrix [13], [14]. Previous studies have implicated integrins as important adhesion molecules in placental development [15], [16], [17], [18]. In mice, targeted mutations in α4, α5, α6, αv, β3, and β8 integrin genes result in placental defects and embryonic lethality [18], [19], [20], [21], [22].

The α7β1 integrin is a laminin receptor that is highly expressed in vascular smooth muscle [23]. Loss of the α7 integrin causes partial embryonic lethality in which 44% of the α7 integrin null embryos die before birth [24], [25]. We have recently demonstrated that loss of the α7 integrin chain leads to cerebral vascular defects which may contribute to the partial embryonic lethality observed in α7 integrin null mice [25]. Studies have shown α7 integrin expression increases in vascular smooth muscle cells (VSMCs) isolated from rats treated with allylamine to induce vascular damage [26]. In addition, treatment of rat VSMCs with platelet derived growth factor (PDGF) increased α7 integrin expression and promoted α7 integrin-mediated adhesion to laminin-1 [27]. Together these results suggest an important role for the α7β1 integrin in vascular development and the progression of vasculoproliferative diseases.

The α7β1 integrin is expressed in the embryonic yolk sac, trophoectoderm cells of the blastocyst and later in the trophoblast layer of the placenta [15]. Although the interaction of the α7β1 integrin with laminin is necessary for trophoblast adhesion during implantation [15], little is known about how loss of the α7 integrin chain affects placental development. Since the placenta is well-vascularized, we hypothesized that loss of the α7 integrin might lead to structural defects that contribute to reduced placental vascular function and partial embryonic lethality.

To investigate if loss of the α7 integrin causes vascular defects in the placenta, we analyzed VSMCs in blood vessels of the placentae from α7 integrin null embryos. Biochemical and histological measurements were used to determine if loss of the α7 integrin in the placenta resulted in vascular defects. The observed vascular smooth muscle abnormalities in placental blood vessels support the hypothesis that the α7β1 integrin has an important role in placental development and suggest loss of this integrin results in placental defects that contribute to the partial embryonic lethality observed in α7 integrin null mice.

Section snippets

Isolation of placentae

Timed homozygous matings were set up to produce wild-type (C57BL6 strain) and α7 integrin null (C57BL6-α7βgal strain) embryos and placentae. Pregnant female mice were euthanized in accordance with a protocol approved by the University of Nevada, Reno Animal Care and Use Committee. ED9.5 and ED13.5 placentae were dissected out of the uterus, rinsed in PBS and frozen in liquid nitrogen cooled isopentane.

Histological staining

ED9.5 placentae were cryoprotected by fixing with 4% paraformaldehyde for 2 h, then washed with

α7 integrin is expressed in placental VSMCs

Loss of α7 integrin results in partial embryonic lethality that begins at ED10.5 [24], [25]. To determine which cells within the placenta express the α7 integrin during this critical period, placentae from embryos at ED9.5 and ED13.5 were analyzed by immunofluorescence using anti-α7 integrin antibodies. The α7 integrin was detected in VSMCs within the fetal blood vessels and placental labyrinth from wild-type ED9.5 and ED13.5 embryos and was absent in the placentae from α7 integrin null mice (

Discussion

This study demonstrates that the α7β1 integrin plays an important role in the vascularization of the placenta. Placental vascularization is a critical event during embryonic development allowing the proper exchange of nutrients, oxygen and removal of wastes between maternal and fetal blood supplies [31], [32], [33], [34].

Previous studies have shown that the α7 integrin is expressed in cells derived from the trophoectoderm of the developing placenta [15]. Our results showed strong

Acknowledgements

The authors would like to thank Dr. Stephen Kaufman, University of Illinois, Urbana, IL, for the α7B (B2 347) antibody and Dr. Maria Valencik, University of Nevada, Reno, NV, for the α5 integrin antibody. The authors would also like to thank Maria Peabody from the University of Nevada, Department of Pathology and Dr. William Hatton from the University of Nevada, Imaging and Morphology Core for technical assistance. This work was supported by grants from the NIH/NCRR P20 RR018751-01 and P20

References (43)

  • S.L. Adamson et al.

    Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta

    Developmental Biology

    (2002)
  • J.C. Cross et al.

    Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta

    Mol Cel Endocrinol

    (2002)
  • G. Pardi et al.

    Placental-fetal Interrelationship in IUGR fetuses – a review

    Placenta

    (2002)
  • J.C. Cross

    Genetic insights into trophoblast differentiation and placental morphogenesis

    Semin Cell Dev Biol

    (2000)
  • M. Hemberger et al.

    Genes governing placental development

    Trends Endocrinol Metab

    (2001)
  • W. Giles et al.

    Fetal umbilical artery flow velocity waveforms and placental resistance, pathological correlation

    Br J Obstet Gynaecol

    (1985)
  • C. Krebs et al.

    Term ovine placental vasculature: comparison of sea level and high altitude condition by corrosion cast and histomorphometry

    Placenta

    (1996)
  • R. Anthony et al.

    Transcriptional regulation in the placenta during normal and compromised fetal growth

    Biochem Soc Trans

    (2001)
  • R. Pollack et al.

    Intrauterine growth retardation: definition, classification, and etiology

    Clin Obstet Gynecol

    (1992)
  • D. Barker et al.

    Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease

    Brit Med J

    (1989)
  • D. Barker et al.

    Fetal and placental size and risk of hypertension in adult life

    Brit Med J

    (1990)
  • Cited by (11)

    • Effect of selective fetectomy on morphology of the mouse placenta

      2016, Placenta
      Citation Excerpt :

      When the influence of these fetal factors is lost after fetal death, the placenta exhibits a characteristic phenotype, which includes reduced fetoplacental vascularity and a blurring of the border between the junctional zone and labyrinth. Interestingly, a strikingly similar placental phenotype was found in Cul4b heterozygotes [38] and Itga7 knockouts [39] when placentas were examined to find a cause for late gestational fetal lethality. Clear placental defects were also found in Fgfrl1 null conceptuses with fetal lethality, whereas the placentas of those that survived to term were structurally normal [40].

    • Myotendinous junction defects and reduced force transmission in mice that lack α7 integrin and utrophin

      2009, American Journal of Pathology
      Citation Excerpt :

      Surprisingly, α7/utr−/− mice were viable and fertile although they did have embryonic lethality. The embryonic lethality in these mice was most likely due to vascular defects identified previously in α7 integrin null mice that cause embryonic vascular hemorrhage.26,27,42 Conversely, mdx/utr−/− and mdx/α7−/− mice develop severe muscular dystrophy and die by 20 weeks and 4 weeks of age, respectively.13,14,28

    View all citing articles on Scopus
    View full text